DJIA 16,501.65 0.00 0.00%
NASDAQ 4,148.34 0.00 0.00%
S&P 500 1,878.61 3.22 0.17%
market minute promo

Novartis

NYSE: NVS

84.59 -1.58 (-1.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $84.59 -1.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $84.62
Previous Close $86.17
Daily Range $83.71 - $84.86
52-Week Range $67.67 - $86.97
Market Cap $205.2B
P/E Ratio 23.29
Dividend (Yield) $2.72 (2.1%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 2,549,858
Average Daily Volume 1,526,581
Current FY EPS $5.23

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

ARIAD Pharmaceuticals, Inc. Battling Back

Since returning to market, ARIAD Pharmaceuticals has captured about half of the patients on Iclusig before it went off the market, but it'll have a hard time competing with Novartis' and Bristol-Myers Squibb's leukemia drugs.

Eli Lilly Q1 Earnings In-Line, Revenues Miss - Analyst Blog

RBC Optimistic on Regeneron Following Lower Sales by Novartis' Lucentis

Novartis' CEO Discusses Q1 2014 Results - Earnings Call Transcript

Botox at the Center of Recent Healthcare M&A Flurry

Novartis AG Discusses Q1 2014 Results (Webcast)

Novartis Signs Deals With GlaxoSmithKline & Eli Lilly - Analyst Blog

Novartis Signs Deals With GlaxoSmithKline & Eli Lilly - Analyst Blog

Novartis Signs Deals with Glaxo, Lilly - Analyst Blog

Novartis Signs Deals with Glaxo, Lilly - Analyst Blog

Novartis, GlaxoSmithKline Exchange Boosts Both Companies' Stocks, 2014 Outlook

Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 24, 2014

Eli Lilly to Acquire Novartis' Animal Health Biz - Analyst Blog

See More NVS News...

NVS's Top Competitors

NVS $84.59 (-1.83%)
Current stock: NVS
JNJ $99.96 (-0.26%)
Current stock: JNJ
MRK $57.53 (0.05%)
Current stock: MRK
GSK $55.51 (0.67%)
Current stock: GSK